Indivior Pharmaceuticals (INDV) Inventory Average (2022 - 2026)

Indivior Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $152.5 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 7.58% year-over-year to $152.5 million in Q1 2026; TTM through Mar 2026 was $152.5 million, a 7.58% decrease from a year earlier, with the FY2025 full-year figure at $160.0 million, up 9.22% from the prior year.
• Inventory Average declined to $152.5 million in Q1 2026 per INDV's latest filing, from $154.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $165.0 million in Q1 2025 and bottomed at $104.5 million in Q4 2022.
• The 4-year median for Inventory Average is $152.5 million (2026), against an average of $143.4 million.
• Across the five-year window, Inventory Average increased 14.83% in 2023 and fell 7.58% in 2026, its largest moves.
• Year by year, Inventory Average stood at $104.5 million in 2022, then gained by 14.83% to $120.0 million in 2023, then climbed by 28.33% to $154.0 million in 2025, then declined by 0.97% to $152.5 million in 2026.
• Per Business Quant, the three latest INDV Inventory Average figures stand at $152.5 million (Q1 2026), $154.0 million (Q4 2025), and $152.0 million (Q3 2025).